Taflan (Tafluprost)

Therapeutic Group : Antiglaucoma

Presentation:

Taflan Sterile Ophthalmic Solution: Each ml contains Tafluprost INN 0.015 mg.
Preservative:
Sodium Perborate BP 0.01%

Indications:

Taflan is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Dosage & Administration:

Instill one drop in the affected eye(s) once daily in the evening.

Contrainidications:

Tafluprost ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product.

Warning & Precautions:

– For ophthalmic use only.
– To avoid possible contamination of the drops, do not touch the dropper tip or to any surface.
– Should be used with caution in patients with active intraocular inflammation (e.g., iritis/uveitis).
– If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes between applications.

Side effects:

The most frequently reported treatment-related side effect is ocular hyperemia. Rare side effects observed include eye irritation and blurred vision.

Use in special groups:

Use in pregnancy: Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Tafluprost ophthalmic solution should be used during pregnancy unless the potential benefit justifies the potential risk to the fetus.
Use in lactation: It is not known whether Tafluprost is excreted in human milk. Caution should be exercised while giving this ophthalmic solution to a nursing mother.
Use in children: Use in pediatric patients is not recommended.
Use in elderly patients: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.

Packing:

Taflan Sterile Ophthalmic Solution: Each plastic dropper bottle contains 3 ml sterile ophthalmic solution.